Drugs / Allogenic plasma aliquots
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04275232 | May → Oct 2025 overdue | ligneous conjunctivitis | Dorothy Bautista, MD | Enrolling by invitation | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogenic plasma aliquots | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04275232 ↗ |
| Route | Topical | “Allogenic plasma aliquots to be used as eye drops in the treatment of recurrences of ligneous conjunctivitis.” NCT04275232 ↗ |